Pap tests for cervical cancer screening test and contraception: analysis of data from the CONSTANCES cohort study

BMC Cancer. 2019 Apr 5;19(1):317. doi: 10.1186/s12885-019-5477-8.

Abstract

Background: In France, a Pap test for cervical cancer screening is recommended every three years for all sexually active women aged 25 to 65 years. Modes of contraception (any or no contraception, with or without a visit to a physician, and with or without a gynecological examination) may influence adhesion to screening: women who use intrauterine device (IUD) should be more up to date with their cervical cancer screening more often than those using other means of contraception. Our objectives were to analyze the association between modes of contraception and Pap tests for screening.

Methods: This cross sectional study is based on the CONSTANCES cohort enabled us to include 16,764 women aged 25-50 years. The factors associated with adhesion to cervical cancer screening (defined by a report of a Pap test within the previous 3 years) was modeled by logistic regression. Missing data were imputed by using multiple imputations. The multivariate analyses were adjusted for sex life, social and demographic characteristics, and health status.

Results: Overall, 11.2% (1875) of the women reported that they were overdue for Pap test screening. In the multivariate analysis there was no significant difference between women using an IUD and those pills or implant of pap test overdue ORa:0.9 CI95% [0.8-1.1], ORa 1.3 CI95% [0.7-2.7] respectively. Women not using contraceptives and those using non-medical contraceptives (condoms, spermicides, etc.) were overdue more often ORa: 2.6 CI95% [2.2-3.0] and ORa: 1.8 CI95% [1.6-2.1] respectively than those using an IUD.

Conclusion: Women seeing medical professionals for contraception are more likely to have Pap tests.

Keywords: Adhesion to screening; Cervical cancer screening; Contraception; Pap test.

MeSH terms

  • Adult
  • Aged
  • Contraception / methods*
  • Contraception / statistics & numerical data
  • Cross-Sectional Studies
  • Early Detection of Cancer / methods
  • Early Detection of Cancer / statistics & numerical data*
  • Female
  • France
  • Humans
  • Mass Screening / methods
  • Mass Screening / statistics & numerical data*
  • Middle Aged
  • Papanicolaou Test / statistics & numerical data*
  • Patient Acceptance of Health Care / statistics & numerical data
  • Patient Compliance / statistics & numerical data
  • Uterine Cervical Neoplasms / diagnosis*
  • Vaginal Smears / statistics & numerical data*
  • Young Adult